FDA approves higher dose version of weight loss drug Wegovy as Novo Nordisk tries to win back market share

2 hours ago 4
ARTICLE AD BOX

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, Feb. 4, 2026.

Tom Little | Reuters

The Food and Drug Administration on Thursday approved a higher dose version of

Read Entire Article